4basebio (XTER:88Q) FCF Margin % : -1,566.43% (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is 4basebio FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. 4basebio's Free Cash Flow for the six months ended in Jun. 2023 was €-4.34 Mil. 4basebio's Revenue for the six months ended in Jun. 2023 was €0.28 Mil. Therefore, 4basebio's FCF Margin % for the quarter that ended in Jun. 2023 was -1,566.43%.

As of today, 4basebio's current FCF Yield % is -3.60%.

The historical rank and industry rank for 4basebio's FCF Margin % or its related term are showing as below:

XTER:88Q' s FCF Margin % Range Over the Past 10 Years
Min: -2479.48 Med: -831.49 Max: -233.66
Current: -1844.88

During the past 4 years, the highest FCF Margin % of 4basebio was -233.66%. The lowest was -2479.48%. And the median was -831.49%.

XTER:88Q's FCF Margin % is ranked worse than
80.78% of 1046 companies
in the Biotechnology industry
Industry Median: -145.305 vs XTER:88Q: -1844.88

4basebio FCF Margin % Historical Data

The historical data trend for 4basebio's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio FCF Margin % Chart

4basebio Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

FCF Margin %

-233.61

-405.29

-1,257.29

-2,480.84

4basebio Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
FCF Margin %	Get a 7-Day Free Trial			-1,140.38	-1,393.58	-2,527.68	-2,424.81	-1,566.43

Competitive Comparison of 4basebio's FCF Margin %

For the Biotechnology subindustry, 4basebio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4basebio's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4basebio's FCF Margin % distribution charts can be found below:

* The bar in red indicates where 4basebio's FCF Margin % falls into.

4basebio FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

4basebio's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-7.641	/	0.308
	=	-2,480.84 %

4basebio's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-4.339	/	0.277
	=	-1,566.43 %

4basebio FCF Margin % Related Terms

Thank you for viewing the detailed overview of 4basebio's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

4basebio (XTER:88Q) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (XTER:88Q) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

4BB:UK

Address

25 Norman Way, Over, Cambridge, GBR, CB24 5QE

Website

https://www.4basebio.com

4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (XTER:88Q) Headlines

No Headlines